212 filings
Page 6 of 11
8-K
6f6nl58z
6 Aug 20
Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:05am
8-K
0ys393n8n 54ur8kr
26 Jun 20
Departure of Directors or Certain Officers
4:05pm
S-8
y8qy337gcddh vou5
25 Jun 20
Registration of securities for employees
4:06pm
DEFA14A
6i67xo
10 Jun 20
Additional proxy soliciting materials
8:10am
8-K
qpd0mnjk4xm u3cy
26 May 20
Other Events
8:05am
EFFECT
anb4zd8kznrv
20 May 20
Notice of effectiveness
12:15am
CORRESP
mealm190i1ff 9ka51
15 May 20
Correspondence with SEC
12:00am
UPLOAD
4dhd2k6n7p
13 May 20
Letter from SEC
12:00am
8-K
tlouak3cq5r
7 May 20
Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:05am
CT ORDER
de3kx1if0 aqyec
1 May 20
Confidential treatment order
12:00am
DEFA14A
4jsku
29 Apr 20
Additional proxy soliciting materials
8:54am
8-K
zr1gfupudpf81n2d14x
8 Apr 20
Regulation FD Disclosure
7:30am
424B5
aprpw
12 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
9iorzxn5hhf3762
12 Mar 20
Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock
12:00am
8-K
yf4srsuodxzloxbd
11 Mar 20
Other Events
12:00am
424B5
flvfga1w01j5v0ndlosk
10 Mar 20
Prospectus supplement for primary offering
9:26pm